IGF1 Antibody, FITC conjugated - Cat. #: CSB-PA08399C0Rb

SKU: CSB-PA08399C0Rb

Size :50ug

Clone Number:

Aliases:IBP1 antibody; IGF I antibody; IGF IA antibody; IGF IB antibody; IGF-I antibody; Igf1 antibody; IGF1_HUMAN antibody; IGF1A antibody; IGFI antibody; IGFIA antibody; Insulin like growth factor 1 (somatomedin C) antibody; Insulin like growth factor 1 antibody; Insulin like growth factor IA antibody; Insulin like growth factor IB antibody; Insulin-like growth factor I antibody; Mechano growth factor antibody; MGF antibody; OTTHUMP00000195080 antibody; OTTHUMP00000195081 antibody; OTTHUMP00000195082 antibody; OTTHUMP00000195083 antibody; OTTHUMP00000195084 antibody; Somatomedia C antibody; Somatomedin C antibody; Somatomedin-C antibody

Product Type:Polyclonal Antibody

Immunogen Species:Homo sapiens (Human)

UniProt ID:P05019

Immunogen:Recombinant Human Insulin-like growth factor I protein (49-118AA)

Raised in:Rabbit

Species Reactivity:Human

Tested Applications:

Background:Receptor tyrosine kinase which mediates actions of insulin-like growth factor 1 (IGF1). Binds IGF1 with high affinity and IGF2 and insulin (INS) with a lower affinity. The activated IGF1R is involved in cell growth and survival control. IGF1R is crucial for tumor transformation and survival of malignant cell. Ligand binding activates the receptor kinase, leading to receptor autophosphorylation, and tyrosines phosphorylation of multiple substrates, that function as signaling adapter proteins including, the insulin-receptor substrates (IRS1/2), Shc and 14-3-3 proteins. Phosphorylation of IRSs proteins lead to the activation of two main signaling pathways: the PI3K-AKT/PKB pathway and the Ras-MAPK pathway. The result of activating the MAPK pathway is increased cellular proliferation, whereas activating the PI3K pathway inhibits apoptosis and stimulates protein synthesis. Phosphorylated IRS1 can activate the 85 kDa regulatory subunit of PI3K (PIK3R1), leading to activation of several downstream substrates, including protein AKT/PKB. AKT phosphorylation, in turn, enhances protein synthesis through mTOR activation and triggers the antiapoptotic effects of IGFIR through phosphorylation and inactivation of BAD. In parallel to PI3K-driven signaling, recruitment of Grb2/SOS by phosphorylated IRS1 or Shc leads to recruitment of Ras and activation of the ras-MAPK pathway. In addition to these two main signaling pathways IGF1R signals also through the Janus kinase/signal transducer and activator of transcription pathway (JAK/STAT). Phosphorylation of JAK proteins can lead to phosphorylation/activation of signal transducers and activators of transcription (STAT) proteins. In particular activation of STAT3, may be essential for the transforming activity of IGF1R. The JAK/STAT pathway activates gene transcription and may be responsible for the transforming activity. JNK kinases can also be activated by the IGF1R. IGF1 exerts inhibiting activities on JNK activation via phosphorylation and inhibition of MAP3K5/ASK1, which is able to directly associate with the IGF1R.

Clonality:Polyclonal

Isotype:IgG

Purification Method:>95%, Protein G purified

Conjugate:FITC

Buffer:Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M PBS, PH 7.4

Form:Liquid

Stroage:Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.

Target Names:IGF1

Research Areas:Cancer; Developmental biology; Signal transduction